Marcio Souza - 14 May 2024 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Executive Officer, Director
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
14 May 2024
Net transactions value
+$21,248
Form type
4
Filing time
20 May 2024, 08:10:14 UTC
Previous filing
14 Feb 2024
Next filing
31 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $21,248 +1,718 +11% $12.37 16,894 14 May 2024 Direct F1
holding PRAX Common Stock 3,000 14 May 2024 Held by spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).